Archives of Virology

, Volume 123, Issue 1–2, pp 47–58 | Cite as

Comparison of immunoblots with neutralizing and complement fixing antibodies in experimental and natural cases of visna-maedi

  • E. G. Torfason
  • M. Gudnadóttir
  • A. Löve
Original Papers


In this study the humoral antibody response in visna-maedi virus disease in sheep during long-term infection was analyzed utilizing immunoblot assays, neutralization tests and complement fixation tests. In immunoblot assays antibodies to several virus specific protein bands were detected, both against the viral envelope glycoproteins and internal proteins of the virus. The immunoblot reaction pattern resembled that found in HIV-1 infection in humans, consistent with reported similar molecular weight of the major proteins of these two viruses. The immunoblot band pattern was compared with the pattern of complement fixing and neutralizing antibodies through the preclinical and clinical course in natural and experimental cases of visna-maedi. Of six immunoblot bands identified as virus specific, the antibody response against threegag products and the majorenv glycoprotein appeared early in infection, at a similar time as the complement fixing antibodies. The response against two proteins, one presumably the transmembrane protein and the other possibly agag precursor, was delayed.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M (1985) Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228: 1091–1094Google Scholar
  2. 2.
    Bosgiraud C, Rucheton M, Coste J, Lemaire JM, Nicolas JA, Simeon de Buochberg M, Beaubatie L (1989) Détection d'anticorps et d'antigènes du virus de visna-maedi par immunotransfert. Ann Rech Vét 20: 187–193Google Scholar
  3. 3.
    Cheevers WP, McGuire TC (1988) The lentiviruses: Maedi/visna, caprine arthritis-encephalitis, and equine infectious anemia. Adv Virus Res 34: 189–215Google Scholar
  4. 4.
    Dawson M (1987) Pathogenesis of maedi-visna. Vet Rec 120: 451–454Google Scholar
  5. 5.
    De Boer GF, Houwers DJ (1979) Epizootology of maedi/visna in sheep. In: Tyrrell DAJ (ed) Aspects of slow and persistent virus infections. Martinus Nijhoff, The Hague, pp 198–220Google Scholar
  6. 6.
    De Boer GF, Terpstra C, Houwers DJ, Hendriks J (1979) Studies in epidemiology of maedi/visna in sheep. Res Vet Sci 26: 202–208Google Scholar
  7. 7.
    Gíslason G (1966) Maedi. In: Dalling T, Robertson A, Boddie GF, Spreull JSA (eds) International encyclopedia of veterinary medicine, vol 3. W Green, Edinburgh, pp 1780–1784Google Scholar
  8. 8.
    Groopman J, Chen FW, Hope JA, Andrews JM, Swift RL, Benton CV, Sullivan JL, Volberding PA, Sites DP, Landesman S, Gold J, Baker L, Craven D, Boches FS (1986) Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis 153: 736–742Google Scholar
  9. 9.
    Gudnadóttir M, Pálsson PA (1966) Host — virus interaction in visna infected sheep. J Immunol 95: 1116–1120Google Scholar
  10. 10.
    Gudnadóttir M, Pálsson PA (1967) Transmission of maedi by inoculation of a virus grown in tissue culture from maedi-affected lungs. J Infect Dis 117: 1–6Google Scholar
  11. 11.
    Gudnadóttir M, Kristinsdóttir K (1967) Complement-fixing antibodies in sera of sheep affected with visna and maedi. J Immunol 98: 663–667Google Scholar
  12. 12.
    Gudnadóttir M, Gíslason G, Pálsson PA (1968) Studies on natural cases of maedi in search for diagnostic laboratory methods. Res Vet Sci 9: 65–67Google Scholar
  13. 13.
    Gudnadóttir M (1972) Strain difference in visna. In: Proceedings 65th Ordinary Meeting of the Society for General Microbiology and 4th Meeting of the North-West European Microbiology Group, University of Bristol, Bristol, EnglandGoogle Scholar
  14. 14.
    Gudnadóttir M (1974) Visna-maedi in sheep. Prog Med Virol 18: 336–349Google Scholar
  15. 15.
    Gudnadóttir M (1979) Visna in sheep. In: Karcher D, Lowenthal A, Strosberg AD (eds) Humoral immunity in neurological disease. Plenum, New York, pp 163–182Google Scholar
  16. 16.
    Haase AT, Baringer JR (1974) The structural polypeptides of RNA slow viruses. Virology 57: 238–250Google Scholar
  17. 17.
    Haseltine WA (1989) Silent HIV infections. N Engl J Med 320: 1487–1489Google Scholar
  18. 18.
    Houwers DJ, Nauta IM (1989) Immunoblot analysis of the antibody response to ovine lentivirus infections. Vet Microbiol 19: 127–139Google Scholar
  19. 19.
    Imagawa DT, Lee MH, Wolinsky SM, Sano K, Morales F, Kwok S, Sninsky JJ, Nishanian PG, Giorgi J, Fahey JL, Dudley J, Visscher BR, Detels R (1989) Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med 320: 1458–1462Google Scholar
  20. 20.
    Kajikawa O, Lairmore MD, DeMartini JC (1990) Analysis of antibody responses to phenotypically distinct lentiviruses. J Clin Microbiol 28: 764–770Google Scholar
  21. 21.
    Lin FH (1978) Polyacrylamide gel electrophoresis of visna virus polypeptides isolated by agarose gel chromatography. J Virol 25: 207–214Google Scholar
  22. 22.
    Mountcastle WE, Harter DH, Choppin PW (1972) The proteins of visna virus. Virology 47: 542–545Google Scholar
  23. 23.
    Norrby E (1985) Variability of antigen epitopes of monotypic viruses. In: Habermehl K-O (ed) Proceedings of fourth international symposium on rapid methods and automation in microbiology and immunology. Springer, Berlin Heidelberg New York Tokyo, pp 83–93Google Scholar
  24. 24.
    Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346–356Google Scholar
  25. 25.
    Pétursson G (1990) Maedi-visna. Etiology and immune response. In: Pétursson G, Hoff-Jørgensen R (eds) Maedi-visna and related diseases. Kluwer, Boston, pp 55–74Google Scholar
  26. 26.
    Ranki A, Valle S-L, Krohn M, Antonen J, Allain J-P, Leuther M, Franchini G, Krohn K (1987) Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet ii: 589–593Google Scholar
  27. 27.
    Saah AJ, Farzadegan H, Fox R, Nishanian P, Rinaldo CR, Jr, Phair JP, Fahey JL, Lee T-H, Polk F, and The Multicenter AIDS Cohort Study (1987) Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, western blot, and radioimmunoprecipitation. J Clin Microbiol 25: 1605–1610Google Scholar
  28. 28.
    Sarngadharan MG, diMarzo Veronese F, Lee S, Gallo RC (1985) Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Cancer Res [Suppl] 45: 4574–4577Google Scholar
  29. 29.
    Sigurdsson B, Thormar H, Pálsson PA (1960) Cultivation of visna virus in tissue culture. Arch Ges Virusforsch 10: 368–381Google Scholar
  30. 30.
    Sonigo P, Alizon M, Staskus K, Klatzmann D, Cole S, Danos O, Retzel E, Tiollais P, Haase A, Wain-Hobson S (1985) Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell 42: 369–382Google Scholar
  31. 31.
    Stanley J, Bhaduri LM, Narayan O, Clements JE (1987) Topographical rearrangements of visna virus envelope glycoprotein during antigenic drift. J Virol 61: 1019–1028Google Scholar
  32. 32.
    Vigne R, Filippi P, Quérat G, Sauze N, Vitu C, Russo P, Delori P (1982) Precursor polypeptides to structural proteins of visna virus. J Virol 42: 1046–1056Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • E. G. Torfason
    • 1
  • M. Gudnadóttir
    • 1
  • A. Löve
    • 1
  1. 1.Virus Laboratories, Department of MicrobiologyUniversity of IcelandReykjavíkIceland

Personalised recommendations